Australia TGA ARTG recordAutologous adipose tissue injection syringe
Australia TGA ARTG Registered Device · Samson Medical Technologies Pty Ltd · Juvaplus SA · Class IIa · Started March 29, 2019
Good Name: Samson Medical Technologies Pty Ltd - Autologous adipose tissue injection syringe
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- March 29, 2019
- Effective Date
- March 29, 2019
- Name
- Juvaplus SA
- Country
- Switzerland
- Address
- Rue de la Maladiere 71C, Neuchatel, Switzerland, CH-2002
Sterile disposable products to be used in conjunction with the Juvaplus Lipopen for local injection of autologous fat.
Access comprehensive regulatory information for Autologous adipose tissue injection syringe in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Samson Medical Technologies Pty Ltd, manufactured by Juvaplus SA in Switzerland. The device registration started on March 29, 2019.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.